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	 The	 reaction	 of	 2,3‐disubstituted	 mercapto	 quinazolines	 with	 2‐hydroxy	 benzaldehyde
(HBAMQ)	 (1),	 2‐hydroxy	 naphthaldehyde	 (HNAMQ)	 (2),	 pyridine‐2‐carboxaldehyde
(PMAMQ)	 (3)	 and	 thiophen‐2‐carboxaldehyde	 (TMAMQ)	 (4),	 and	 with	metals	 like	 Rh(III),
Ru(III),	and	Ag(I)	in	the	presence	of	piperidine	resulted	in	the	formation	of	their	respective
complexes	 by	 physicochemical	 methods.	 The	 newly	 synthesized	 complexes	 were
characterized	 by	 elemental	 analysis,	magnetic	 data,	 and	 spectroscopic	 techniques	 like	 UV‐
Visible,	 IR	 and	 1H	 NMR,	 respectively.	 These	 compounds	 were	 also	 evaluated	 for	 their
antimicrobial	activities.	
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1.	Introduction	
	
Although	 several	 classes	 of	 antimicrobial	 compounds	 are	
presently	available,	the	resistance	of	microorganisms	to	these	
drugs	has	been	constantly	 emerging.	 In	order	 to	address	 this	
serious	medical	problem,	the	medicinal	chemists	have	focused	
their	 attention	 on	 organic	 compounds	 and	 natural	 products	
but	 not	 on	metallo‐organic	 entities	 in	 search	 of	 a	 new	 drug.	
Quinazolines	are	bicylic	 compounds	which	play	an	 important	
role	 in	 the	 synthetic	 organic	 chemistry.	 Among	 which,	
particularly	 those	 which	 are	 C‐2	 and	 N‐3	 di‐substituted	
quinazoline‐(3H)‐4‐ones	 are	 reported	 to	 be	 physiologically	
and	 pharmacologically	 active	 and	 find	 applications	 in	 the	
treatment	 of	 several	 diseases	 such	 as	 leprosy,	 mental	
disorders	etc.	These	compounds	are	also	used	as	antibacterial,	
antifungal,	 antitubercular,	 anticonvulsant,	 antipyretic,	 anti‐
amoebic,	 antifertile	and	plant	growth	regulating	agents	 [1‐6].	
In	analytical	chemistry,	quinazolines	also	 find	applications	by	
acting	 as	 multidentate	 ligands	 with	 metals	 usually	 from	 the	
transition	group	[7].		
Schiff	 bases	 constitute	 an	 important	 class	 of	 organic	
compounds	 for	 which	 they	 are	 endowed	 with	 synthetic	
flexibility	 and	 can	 be	 obtained	 with	 varied	 substitutions	
widely	 by	 the	 selection	 of	 appropriate	 reactions.	 These	
compounds	have	also	been	projected	as	promising	pesticides,	
fungicides	 and	 bacteriocides	 [8‐10].	 They	 possess	 a	 wide	
spectrum	 of	 medicinal	 properties	 as	 they	 are	 active	 against	
tuberculosis,	 leprosy,	 viral	 infections	 and	 certain	 types	 of	
tumors	etc.	 [11‐19].	Various	studies	have	also	shown	that	the	
azomethine	group,	having	a	lone	pair	of	electrons	in	either	a	p	
or	 sp2	 hybridized	 orbital	 on	 triagonally	 hybridized	 nitrogen	
has	 considerable	 biological	 importance.	 It	 was	 often	 been	
thought	that	the	biological	activity	of	these	compounds	is	due	
to	 their	 ability	 to	 chelate	 metal	 ions.	 The	 synthesis	 and	
characterization	 of	 metal	 complexes	 with	 bioactive	 organic	
ligands,	 particularly	 the	 Schiff	 bases,	 is	 one	 among	 the	
promising	fields	for	the	research,	as	the	metal	ion	association	
exerts	 a	 synergistic	 effect	 on	 the	 activity	 of	 the	 free	 ligands	
[20‐24].	
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As	 the	 Schiff	 base	 derivatives	 of	 quinazolines	 and	 their	
metal	 complexes	 play	 an	 important	 role	 in	 many	 biological	
processes,	 and	 our	 earlier	 research	 work	 involved	 the	
synthesis,	 characterization,	 and	 bioactivity	 evaluation	 of	
quinazolyl	 based	 Schiff	 bases	 [25‐27],	 their	metal	 complexes,	
and	based	on	the	encouraging	results	obtained	with	regard	to	
the	biological	activity	of	these	systems,	through	this	paper,	we	
report	the	synthesis	and	characterization	of	the	ligand	systems	
obtained	 by	 the	 reaction	 of	 2,3‐disubtituted	 mercaptoquina‐
zoline	 with	 A,	 B,	 C,	 D	 to	 result	 3‐((2‐hydroxy	 benzylidene)	
amino)‐2‐thioxo‐2,	3‐dihydroquinazolin‐4(1H)‐one	(1),	3‐(((2‐
hydroxynaphthalen‐1‐yl)methylene)amino)‐2‐thioxo‐2,	 3‐di	
hydroquinazolin‐4(1H)‐one	 (2),	 3‐((pyridin‐2‐ylmethylene)	
amino)‐2‐thioxo‐2,	3‐dihydroquinazolin‐4(1H)‐one	 (3)	 and	3‐
((thiophen‐2‐ylmethylene)amino)‐2‐thioxo‐2,3‐dihydroquina‐
zolin‐4(1H)‐one	 (4)	 and	 their	 Rh(III),	 Ru(III),	 and	 Ag(I)	
complexes	by	physicochemical	methods	(Scheme	1)	and	their	
antimicrobial	 activity	 against	 different	 types	 of	 bacteria	 and	
fungal	species.	
	
2.	Experimental	
	
2.1.	Instrumentation		
	
The	 process	 of	 elemental	 analyses	 was	 carried	 out	 by	
means	 of	 Perkin	 Elmer	 2400	 CHN	 elemental	 analyzer	 at	
Osmania	 University,	 Hyderabad,	 India.	 The	magnetic	 suscep‐
tibility	studies	of	the	metal	complexes	were	recorded	by	using	
magnetic	 susceptibility	 meter	 MS2G,	 single	 frequency	 sensor	
Barington	Company,	India.	The	infrared	spectra	of	the	ligands	
and	 the	metal	complexes	were	recorded	 in	KBr	pellets	 in	 the	
range	4000‐400	 cm‐1	on	Perkin	Elmer‐BX	spectrophotometer	
at	 central	 instrumentation	 center,	 Kakatiya	 University,	
Warangal,	India.	The	electronic	spectra	of	the	metal	complexes	
in	DMF	were	recorded	on	ELICO	SL‐159	UV‐VIS	spectrophoto‐
meter	and	Systronics	Double	beam	UV‐VIS	spectrophotometer,	
2201	 at	 Chaitanya	 Degree	 and	 Post	 Graduate	 College,	
Hanamkonda,	 Warangal,	 India.	 1H	 NMR	 and	 13C	 NMR	 were	
recorded	 in	DMSO‐d6	 (Bruker	 Aspect	 AM‐400	 instrument)	 at	
400	and	100	MHz,	 respectively.	The	chemical	 shift	values	 (δ)	
are	given	in	ppm.		
	
2.2.	Synthesis	of	ligands	
	
All	the	chemicals	used	were	AR	and	BDH	grade.	3‐Amino‐
2‐mercapto‐quinazoline‐4‐(3H)‐ones	 (1)	 was	 prepared	 as	
reported	 earlier	 [28].	 The	 ligands	HBAMQ,	HNAMQ,	 PMAMQ,	
and	 TMAMQ	 were	 synthesized	 by	 refluxing	 equimolar	
methanolic	 solutions	 of	 3‐amino‐2‐thioxo‐2,3‐dihydro	 quina‐
zolin‐4(1H)‐one	(1)	and	the	respective	aldehydes	in	presence	
of	 few	 drops	 of	 piperidine	 for	 3	 to	 6	 h.	 The	 solids	 that	
separated	during	 reflux	were	 filtered,	washed	with	methanol	
and	recrystallized	from	hot	dry	methanol.	
The	 reactions	 of	 aryl	 aldehydes	 like	 A,	 B,	 C,	 D	 (1	mmol)	
with	 3‐amino‐2‐mercapto‐quinazolin‐4(3H)‐one	 in	 the	
presence	 of	 few	 drops	 of	 piperidine	 as	 a	 base	 catalyst	 were	
carried	out	in	methanol	and	refluxed	on	hot	water	bath	for	3‐6	
h	(Scheme	1).	The	crude	products	obtained	were	purified	from	
methanol	and	recrystallized	by	hot	dry	methanol.		
3‐((2‐Hydroxybenzylidene)amino)‐2‐thioxo‐2,	 3‐dihydro	
quinazolin‐4(1H)‐one	 (HBAMQ):	 Color:	 Yellow	 solid.	 Yield:	
78%.	M.p.:	188‐190	°C.	FT‐IR	(KBr,	,	cm‐1):	3200	(NH),	3455	
(OH),	1718	(C=O),	1583	(C=N).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	
ppm):	6.90‐6.96	(m,	2H,	Ar‐H),	7.21‐7.30	(m,	2H,	Ar‐H),	7.30‐
7.40	(d,	2H,	Ar‐H),	7.64‐7.84	(m,	1H,	Ar‐H),	8.02	(d,	1H,	Ar‐H),	
8.70	 (s,	1H,	N=CH),	11.43	(s,	1H,	NH),	11.849	 (s,	1H,	OH).	 13C	
NMR	(100	MHz,	DMSO‐d6,	δ,	ppm):	116.8,	117.8,	119.2,	119.6,	
123.1,	 124.4	 125.7,	 126.6,	 130.2,	 131.2,	 134.7,	 147.8,	 148.2,	
157.7,	161.6.	Anal.	calcd.	for	C15H11N3O2S:	C,	60.59;	H,	3.73;	N,	
14.13;	Found:	C,	60.26;	H,	3.69;	N,	14.02%.	
3‐(((2‐Hydroxynaphthalen‐1‐yl)methylene)amino)‐2‐thioxo‐
2,3‐dihydroquinazolin‐4(1H)‐one	 (HNAMQ):	 Color:	 Mustard	
yellow	solid.	Yield:	82%.	M.p.:	226‐228	°C.	FT‐IR	(KBr,	,	cm‐1):	
3242	(NH),	3450	(OH),	1723	(C=O),	1586	(C=N).	1H	NMR	(400	
MHz,	DMSO‐d6,	δ,	ppm):	7.24‐7.27	(m,	2H,	Ar‐H	),	7.37‐7.42	(m,	
2H,	Ar‐H),	7.57‐7.60	(t,	1H,	Ar‐H),	7.67‐7.80	(t,	1H,	Ar‐H),	7.86‐	
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7.91	 (m,	 2H,	Ar‐H),	 8.01‐8.03	 (d,	 1H,	Ar‐H),	8.14‐8.16	 (d,	 1H,	
Ar‐H),	9.70	(s,	1H,	N=CH),	13.2	(s,	1H,	OH),	11.5	(s,	1H,	NH).	13C	
NMR	 (100	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 δ	 109.3,	 117.93,	 119.56,	
120.83,	 123.32,	 123.90,	 125.85,	 126.64,	 127.99,	 128.20,	
129.36,	 132.12,	 132.43,	 134.84,	 145.61,	 148.18,	 148.66,	
157.95,	161.7.	Anal.	calcd.	for	C19H13N3O2S:	C,	65.69;	H,	3.77;	N,	
12.10.	Found:	C,	65.39;	H,	3.67;	N,	11.98%.		
3‐((Pyridin‐2‐ylmethylene)amino)‐2‐thioxo‐2,	 3‐dihydro	
quinazolin‐4(1H)‐one	 (PMAMQ):	 Color:	 Light	 brown	 solid.	
Yield:	80%.	M.p.:	130‐132	°C.	FT‐IR	(KBr,	,	cm‐1):	3447	(NH),	
1685	(C=O),	1584	(C=N).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	
7.21‐7.26	(m,	2H,	Ar‐H),	7.31‐7.32	(m,	2H,	Ar‐H),	7.40‐7.42	(d,	
2H,	Ar‐H),	7.52‐7.54	(m,	1H,	Ar‐H),	7.94	(d,	1H,	Ar‐H),	8.72	(s,	
1H,	N=CH),	11.3	 (s,	1H,	NH).	 13C	NMR	(100	MHz,	DMSO‐d6,	 δ,	
ppm):118.2,	 123.4,	 124.4,	 125.8,	 126.5,	 134.6,	 137.0,	 137.1,	
148.6	134.7,	149.0,	149.7,	152.2,	154.1,	161.6.	Anal.	calcd.	 for	
C14H10N4OS:	 C,	 59.56;	 H,	 3.57;	 N,	 19.85.	 Found:	 C,	 59.37;	 H,	
3.53;	N,	19.69%.	
3‐((Thiophen‐2‐ylmethylene)amino)‐2‐thioxo‐2,	 3‐dihydro	
quinazolin‐4(1H)‐one	 (TMAMQ):	 Color:	 White	 solid.	 Yield:	
81%.	M.p.:	140‐142	°C.	FT‐IR	(KBr,	,	cm‐1):	3447	(NH),	1685	
(C=O),	 1585	 (C=N).	 1H	 NMR	 (400	 MHz,	 DMSO‐d6,	 δ,	 ppm):	
7.02‐7.10	(m,	2H,	Ar‐H),	7.12‐7.14	(m,	2H,	Ar‐H),	7.24‐7.36	(d,	
1H,	Ar‐H),	7.54‐7.60	(m,	1H,	Ar‐H),	7.72	(d,	1H,	Ar‐H),	8.15	(s,	
1H,	N=CH),	11.4	 (s,	1H,	NH).	 13C	NMR	(100	MHz,	DMSO‐d6,	 δ,	
ppm):	113.7,	116.3,	122.7,	126.7,	128.2,	132.5,	133.90,	134.6,	
134.7,	138.8,	143.8,	148.7,	157.2.	Anal.	calcd.	for	C13H9N3OS2:	C,	
54.34;	H,	3.16;	N,	14.62.	Found:	C,	53.96;	H,	3.03;	N,	14.52%.	
	
2.3.	Synthesis	of	metal	complexes	
	
Rh(III),	 Ru(III)	 and	 Ag(I)	 complexes	 were	 prepared	 by	
taking	RhCl3,	RuCl3	and	AgNO3	as	their	respective	salts.	In	the	
preparation	 of	 all	 the	 metal	 complexes,	 the	 metal	 and	 the	
ligand	were	combined	in	1:1	or	1:2	mole	ratio	(the	metal	being	
in	 slight	 excess	 of	what	 the	 ratio	 is	 required)	 using	 required	
quantities	of	THF,	DMSO,	hot	methanol	and/or	ethanol	for	the	
ligands	 and	 metal	 salts	 so	 as	 to	 affect	 their	 solubility.	 The	
contents	were	 refluxed	 on	 a	water	 bath	 for	 about	 8‐12	 h	 by	
maintaining	 the	 pH	 of	 the	 solution	 8.2‐9.5.	 The	 solid	 that	
separated	 was	 filtered,	 washed	 with	 water,	 hot	 methanol,	
ether	and	vacuum	dried	over	CaCl2.	
The	 reaction	 of	 optically	 active	 chiral	 Schiff	 base	 ligands	
that	 contains	 potential	 donor	 sites	 viz,	 azomethine	 nitrogen,	
phenolic	 oxygen	 and	 carbonyl	 oxygen	 with	 different	 metal	
salts	 like	 RhCl3,	 RuCl3	 and	 AgNO3	 yielded	 their	 respective	
complexes	(Scheme	2	and	3).	
	
2.4.	Assay	of	antibacterial	activity	
	
In	 vitro	 antibacterial	 activity	 of	 the	 ligands	 HBAMQ,	
HNAMQ,	 PMAMQ,	 and	TMAMQ,	 and	 their	Rh(III),	 Ru(III)	 and	
Ag(I)	 complexes	were	 assayed	with	 two	 concentrations	 (600	
and	 900	 μg/mL)	 against	 six	 representative	 Gram‐positive	
bacteria	 (Bacillus	 subtilis,	 Bacillus	 megaterium,	 Bacillus	
pumilus,	 Staphylococcus	 aureus,	 Enterobacter	 aerogenes	 and	
Streptococcus	 pyogenes)	 and	 four	 representative	 Gram‐
negative	 bacteria	 (Escherichia	 coli,	 Klebsiella	 pneumoniae,	
Proteus	 vulgaris,	 Enterococcus	 faecalis)	 using	 broth	 dilution	
method	 recommended	 by	 National	 Committee	 for	 clinical	
laboratory	 standards	 [29].	 Bacteria	were	 grown	 overnight	 in	
Luria‐Bertani	(LB)	broth	at	37	°C	harvested	by	centrifugation	
and	 then	 washed	 twice	 with	 sterile	 distilled	 water.	 Stock	
solutions	 of	 the	 total	 compounds	 were	 dissolved	 in	 DMSO	
solvent.	 Each	 stock	 solution	was	diluted	with	 standard	broth	
method.	 The	 inhibition	 of	 microbial	 growth	 under	 standar‐
dized	 conditions	 was	 utilized	 to	 demonstrate	 antibacterial	
action	 of	 compound.	 Streptomycin	 was	 used	 as	 a	 standard	
drug	for	comparison.	
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Scheme	3	
	
2.5.	Assay	of	antifungal	activity	
	
In	 vitro	 antifungal	 activity	 of	 the	 Schiff	 base	 ligands	 and	
their	 complexes	 were	 assayed	 against	 fungal	 organisms	 viz,	
Candida	 albicans,	 Fusarium	 oxysporum,	 Drechslera	 and	
Colletotrichum	 falcatum.	 The	 test	 organisms	 were	 grown	 for	
48	h	at	25	°C.	Yeast	Extract‐Peptone‐Dextrose	(YPD)	broth	(1	
%	yeast	extract,	2	%	peptone	and	2	%	dextrose)	harvested	by	
centrifugation	and	then	washed	with	sterile	distilled	water.	All	
the	 newly	 synthesized	 compounds	 were	 tested	 in	 four	
concentrations,	 i.e.,	 300,	 600,	 900,	 and	 1200	 μg/mL.	 Itrazole	
was	used	as	a	standard	drug	for	comparison.	
	
3.	Results	and	discussion	
	
3.1.	Chemistry	
	
The	newly	synthesized	complexes	were	characterized	and	
supported	 by	 elemental	 analysis,	 magnetic,	 IR,	 1H	 NMR,	 13C	
NMR	 and	 electronic	 spectral	 data.	 The	 obtained	 Schiff	 base	
ligands	 are	 stable	 at	 room	 temperature,	 non‐hygroscopic,	
insoluble	 in	 water	 and	 slightly	 soluble	 in	 methanol	 and	
acetone	 and	 fairly	 soluble	 in	 DMF.	 The	 novel	 complexes	 are	
powdered	 like,	 para,	 diamagnetic,	 colored	 and	 stable	 in	 the	
solid	 state	 under	 normal	 laboratory	 conditions.	 They	 are	
soluble	in	polar	solvents	such	as	DMF	or	DMSO.	
	
3.2.	Elemental	and	analytical	data	
	
The	 analytical	 data	 presented	 in	 Table	 1,	 confirms	 the	
assigned	composition	of	the	ligand	and	the	complex.	It	may	be	
seen	 from	 the	 table	 that	 the	 experimental	 values	 are	 in	 fair	
agreement	with	the	calculated	ones.	
	
3.3.	Magnetic	moment		
	
The	 room	 temperature	 magnetic	 moment	 data	 obtained	
for	 the	 present	 complexes	 reveals	 that,	 the	 present	 Rh(III)	
complexes	 are	 found	 diamagnetic	 suggesting	 their	 low	 spin	
nature.	The	magnetic	moment	values	for	the	Ru(III)	complexes	
reveals	 that	 these	 are	 low	 spin	 in	 nature.	 The	 low	 spin	
complexes	with	t2g5	configuration	are	expected	to	have	orbital	
contribution	to	magnetic	moment	and	show	a	value	around	2.0	
B.M.	The	present	Ru(III)	complexes	are	found	to	have	values	in	
the	 range	 of	 1.79‐1.80	 by	 indicating	 them	 to	 be	 of	 low	 spin	
octahedral	 complex	 [30].	 The	 magnetic	 moment	 values	
observed	 for	 Ag(I)	 complexes	 were	 found	 with	 no	 magnetic	
moment	and	hence	they	are	diamagnetic	in	nature.	
	
3.4.	FT‐IR	spectral	data	
	
The	ligands	HBAMQ,	HNAMQ	reveals	a	sharp	band	around	
1718	cm‐1	and	the	ligands	PMAMQ,	TMAMQ	around	1680	cm‐1	
due	to	νC=O	of	quinazoline	ring	 (Table	2).	This	band	appears	
unshifted	in	the	metal	complexes	of	HBAMQ	and	HNAMQ	but	it	
is	 lower	 shifted	 in	 the	 metal	 complexes	 of	 PMAMQ	 and	
TMAMQ,	 suggesting	 non‐involvement	 of	 the	 group	 in	
coordination	 with	 respect	 to	 HBAMQ	 and	 HNAMQ	 and	
involvement	 of	 the	 same	 in	 coordination	 with	 respect	 to	
PMAMQ	and	TMAMQ	[31].	It	is	observed	that	all	these	ligands	
do	not	reveal	a	band	in	the	range	2600‐2550	cm‐1	due	to	νS‐H	
indicating	 that	 this	 group	 has	 undergone	 tautomerism	 into	
thione	 form.	Further,	 these	 ligands	 reveal	 bands	 correspond‐
ding	 to	 the	 thioamide	 (H‐N‐C=S)	 group.	 These	 bands	 remain	
unshifted	in	their	complexes	indicating	non‐involvement	of	‘S’	
in	co‐ordination.	
Further,	 to	 report	 that	 the	 HBAMQ	 and	 HNAMQ	 record	
small	intensity	bands	in	the	region	3455‐3200	cm‐1,	the	one	at	
higher	 frequency	due	 νO‐H	and	 the	other	 at	 lower	 frequency	
due	 to	 νN‐H.	The	higher	 frequency	band	 corresponding	νO‐H	
disappears	 in	 their	 metal	 complexes	 indicating	 the	 involve‐
ment	 of	 O‐hydroxy	 group	 in	 complexation	 through	 deproto‐
nation,	where	as	the	νN‐H	band	persists	at	the	same	frequency	
in	their	complexes.	
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Table	1.	Elemental	analysis	of	the	synthesized	complexes.	
Complex	 Molecular	formula	 Found	(Calcd.)	%	
M C N	 S
Rh(HBAMQ‐H)2(H2O)2Cl	 C30H24ClN6O6RhS2 13.23	
(13.42)	
46.75
(46.98)	
10.75	
(10.96)	
8.21
(8.36)	
Rh(PMAMQ)2(H2O)2Cl3	 C28H24Cl3N8O4RhS2 12.35
(12.71)	
41.75
(41.52)	
	13.52	
(13.84)	
7.40
(7.92)	
Rh(TMAMQ)2(H2O)2Cl3	 C26H22Cl3N6O4RhS4 12.28
(12.55)	
37.86
(38.08)	
	10.01	
(10.25)	
15.40
(15.64)	
Rh(HNAMQ‐H)2(H2O)2Cl	 C38H28ClN6O6RhS2	 11.97	
(11.87)	
54.24	
(52.63)	
9.52	
(9.69)	
6.64	
(7.39)	
Ru(HBAMQ‐H)2(H2O)2Cl		 C30H24ClN6O6RuS2	 13.13	
(13.21)	
46.87	
(47.09)	
10.61	
(10.98)	
8.12	
(8.38)	
Ru(HNAMQ‐H)2(H2O)2Cl	 C38H28ClN6O6RuS2	 11.47	
(11.68)	
52.45	
(52.75)	
9.65	
(9.71)	
7.34	
(7.41)	
Ru(PMAMQ)2(H2O)2Cl3	 C28H24Cl3N8O4RuS2 12.43
(12.51)	
41.02
(41.62)	
14.01	
(13.87)	
8.10
(7.93)	
Ru(TMAMQ)2(H2O)2Cl3	 C26H22Cl3N6O4RuS4 12.24
(12.35)	
37.45
(38.17)	
.	10.12	
(10.27)	
15.02
(15.67)	
Ag(HBAMQ‐H)	 C15H10AgN3O2S 26.23
(26.69)	
44.23
(44.57)	
10.31	
(10.40)	
7.58
(7.93)	
Ag(HNAMQ‐H)	 C19H12AgN3O2S	 23.38	
(23.75)	
49.78	
(50.24)	
8.89	
(9.25)	
6.93	
(7.06)	
Ag(PMAMQ)(NO3)		 C14H10AgN5O4S	 23.45	
(23.85)	
	37.02	
(37.19)	
	15.25	
(15.49)	
	7.02	
(7.09)	
Ag(TMAMQ)(NO3)	 C13H9AgN4O4S2 23.21
(23.59)	
34.17
(34.15)	
	12.03	
(12.25)	
14.98
(14.00)	
	
	
Table	2.	FT‐IR	spectral	data	of	the	synthesized	ligands	and	Rh(III),	Ru(III)	and	Ag(I)	complexes.	
Compound	 νN‐H	 νO‐H	 νC=O	 νC=N	
HBAMQ	 3200	 3455 1718 1583	
Rh‐HBAMQ	 3206	 ‐ 1729 1543	
Ru‐HBAMQ	 3215	 ‐	 1724	 1550	
Ag‐HBAMQ	 3246	 ‐	 1720	 1517	
HNAMQ	 3242	 3450 1723 1586	
Rh‐HNAMQ	 3228	 ‐	 1724	 1569	
Ru‐HNAMQ	 3219	 ‐ 1726 1564	
Ag‐HNAMQ	 3216	 ‐ 1687 1550	
PMAMQ	 3447	 ‐ 1685 1584	
Rh‐PMAMQ	 3429	 ‐ 1662 1572	
Ru‐PMAMQ	 3456	 ‐ 1660 1580	
Ag‐PMAMQ	 3469	 ‐ 1655 1565	
TMAMQ	 3447	 ‐	 1685	 1585	
Rh‐TMAMQ	 3422	 ‐ 1666 1565	
Ru‐TMAMQ	 3422	 ‐	 1648	 1569	
Ag‐TMAMQ	 3448	 ‐	 1660	 1574	
	
	
A	medium	intensity	band	seems	to	make	its	presence	in	all	
ligands	around	~1586	cm‐1	due	to	νC=N	has	been	found	lower	
shifted	by	about	30	cm‐1	in	all	the	complexes	pointing	out	that	
the	 nitrogen	 of	 this	 group	 is	 involved	 in	 coordination.	 In	 the	
ligands	HBAMQ	and	HNAMQ,	the	coordination	through	oxygen	
of	 phenolic	 group	 and	 nitrogen	 of	 azomethine	 group	 of	 the	
ligands	in	all	the	complexes	is	substantiated	by	the	appearance	
of	non‐ligand	bands	in	the	far	infrared	region	around	500	and	
400	 cm‐1	 assignable,	 respectively,	 to	 νM‐O	 and	 νM‐N	
vibrations.	
In	 the	 ligands	PMAMQ	and	TMAMQ	small	 intensity	bands	
appear	at	1380	cm‐1	due	to	νC‐N	(pyridine	cyclic)	at	780	cm‐1	
due	 to	 νC‐S	 (Thiophene	 cyclic)	 remain	 unshifted	 in	 their	
complexes	 suggesting	 non‐involvement	 of	 N	 and	 S	 atom	
present	in	the	ligands	PMAMQ	and	TMAMQ	in	coordination.	
Based	on	all	 these	observations,	 it	may	be	concluded	that	
HBAMQ	and	HNAMQ	ligands	behave	towards	the	metal	ions	as	
mononegative	 bidentate	 ligands	 coordinating	 through	
phenolic	 oxygen	 and	 azomethine	 nitrogen	where	 as	 PMAMQ	
and	 TMAMQ	 behave	 towards	 the	 metal	 ions	 as	 neutral	
bidentate	 ligands	 coordinating	 through	 quinazoline	 carbonyl	
group	and	azomethine	nitrogen.	
	
3.5.	UV‐Visible	spectral	data		
	
The	UV‐Visible	spectra	of	all	the	complexes	were	obtained	
in	methanolic	solution.	The	Rh(III)	complexes	of	all	the	ligands	
each	 show	 three	 peaks	 in	 their	 electronic	 spectra	 around	
24,890	and	33,333	cm‐1	which	may	be	assigned	respectively	to	
the	 transitions	 1A1g	→	 1T1g	 and	 1A1g	→	1T2g	 and	 the	other	band	
appearing	at	39,215	cm‐1	is	due	to	charge	transfer	transitions	
of	 octahedral	 geometry	 The	 present	 Ru(III)	 complexes	 of	 all	
the	ligands	reveal	three	peaks	in	the	region	11,490‐25,000	cm‐
1	which	may	be	assigned	 in	the	 increasing	order	of	 frequency	
to	 the	 transitions	 2T2g	→	 4T1g	 ,	 2T2g	→	 4T2g,	 2T2g	→	 2A2g	 ,	 2T1g	 of	
octahedral	 geometry.	 These	 observations	 coupled	 with	 the	
other	data,	which	suggest	an	octahedral	geometry	for	Rh(III),	
Ru(III)	complexes.	On	 the	basis	of	analytical,	magnetic,	 IR,	 1H	
NMR	 and	 13C	 NMR	 data	 the	 Ag(I)	 complexes	 have	 been	
assigned	linear	geometry.		
	
3.6.	Antibacterial	activity	
	
The	 results	 of	 the	 antibacterial	 screening	 of	 the	 ligands	
and	their	metal	complexes	are	incorporated	in	Table	3.	Based	
on	the	observations,	it	was	revealed	that	the	activity	profiles	of	
the	 ligands	 and	 their	 metal	 complexes	 screened	 against	 the	
microorganisms	 are	 varying	 as	 some	 of	 the	 compounds	 are	
active	 either	 significantly	 or	marginally	while	 others	 are	 not.	
The	 results	 indicate	 that	 most	 of	 the	 compounds	 are	
ineffective	in	inhibiting	the	growth	of	Gram	+ve	and	Gram	‐ve	
bacteria.	 Where	 the	 compounds	 are	 active,	 they	 exert	
relatively	more	activity	on	 some	 species	of	Gram	+ve	and	on	
some	 species	 of	 Gram	 ‐ve	 bacteria.	 All	 the	 ligands	 exert	
significant	 activity	 against	 the	 microorganisms	 though	 in	
different	 level.	 The	 compounds	 Rh‐PMAMQ,	 Ru‐HMAMQ	 and	
Ag‐TMAMQ	exert	relatively	good	activity.	
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Table	3.	In	vitro	antibacterial	activity	of	the	synthesizd	ligands	*.		
Microorganism	 Conc.	(µg/mL)	 Compound	and	zone	of	inhibition	in	mm	
Rh(III)	complex Ru(III)	complex Ag(I)	complex	 Streptomycin
L1	 L2	 L3	 L4	 L1	 L2	 L3	 L4	 L1	 L2	 L3	 L4	
Escherichia	
coli		
600	 2.8	 1.5	 2.5 1.8 2.8 2.8 2.1 2.3 NA 1.8 1.2	 NA	 3.0	
900	 5.6	 3.0	 4.9 3.6 4.9 4.8 4.2 4.6 NA 3.6 2.4	 NA	 6.1	
Proteus		
vulgaris	
600	 2.1	 3.0	 4.1 1.9 2.4 4.2 2.9 2.1 1.8 1.5 1.6	 1.2	 8.9	
900	 4.2	 6.2	 8.2	 3.8	 4.8	 8.4	 6.0	 4.2	 3.6	 3.0	 3.2	 2.4	 16.0	
Enterococcus		
faecalis	
600	 1.9	 3.1	 2.2	 2.0	 2.0	 3.0	 3.1	 1.8	 3.7	 1.2	 3.0	 4.8	 12.8	
900	 4.0	 6.2	 4.1	 4.2	 4.0	 6.0	 6.2	 3.6	 7.2	 2.4	 6.0	 9.2	 20.3	
Klebsiella		
pneumoniae	
600	 2.0	 3.1	 2.1 1.2 3.1 1.8 2.0 NA 1.7 1.8 1.2	 1.2	 3.2	
900	 4.0	 6.2	 4.2 2.4 6.2 3.6 4.2 NA 3.4 3.6 2.4	 3.0	 6.5	
Enterobacter		
aerogenes	
600	 NA	 2.0	 3.0 1.5 2.1 1.9 1.5 1.2 3.0 3.5 1.2	 3.8	 4.4	
900	 NA	 4.2	 6.0 3.0 4.2 3.8 3.0 2.4 6.0 7.0 2.4	 7.6	 8.7	
Bacillus		
subtilis	
600	 1.2	 2.1	 3.7 1.8 6.1 4 6.5 2.0 2.1 NA 1.8	 1.5	 8.4	
900	 4.2	 4.4	 7.2 3.6 12.0 8.0 12.9 4.0 4.2 NA 3.6	 3.0	 16.2	
Bacillus		
megaterium	
600	 NA	 1.8	 3.0 NA 5.8 5.2 3.5 1.5 2.8 1.2 3.0	 2.0	 6.2	
900	 NA	 3.6	 6.0	 NA	 10.6	 10.4	 7.0	 3.0	 5.6	 2.5	 6.0	 4.0	 12.8	
Bacillus		
pumilus	
600	 1.5	 2.0	 1.5	 2.8	 6.0	 4.9	 2.8	 3.0	 3.1	 3.0	 1.5	 4.1	 7.2	
900	 3.0	 4.1	 3.0	 5.2	 12.0	 10.0	 5.0	 6.1	 6.2	 6.0	 3.0	 8.2	 14.5	
Staphylococcus		
aureus	
600	 3.0	 4.8	 3.0 1.8 2.4 1.8 1.5 1.8 3.0 1.5 4.8	 5.2	 10.3	
900	 6.1	 9.2	 6.0	 3.6	 4.8	 3.6	 3.0	 3.7	 6.0	 3.0	 9.6	 10.1	 20.0	
Streptococcus		
pyogenes	
600	 1.5	 NA	 2.2 2.8 1.8 NA 2.5 6.0 NA 3.0 2.2	 NA	 8.1	
900	 3.1	 NA	 4.4 5.6 3.6 NA 3.0 12.1 NA 6.0 4.4	 NA	 16.4	
*	NA:		Not	applicable.	
	
Table	4.	In	vitro	antifungal	activity	of	the	synthesized	ligands.	
Microorganism	 Conc.		
(µg/mL)	
Compound	and	zone	of	inhibition
Rh(III)	complex	 Ru(III)	complex	 Ag(I)	complex	 Itrazole	
L1	 L2	 L3	 L4 L1 L2 L3 L4 L1 L2 L3	 L4	
Candida	
albicans		
300	 3.9	 3.4	 2.7	 3.2 3.2 3.8 3.0 3.4 3.2 3.0	 NA	 3.1	 2.6
600	 3.0	 4.3	 4.6	 5.0 5.5 4.8 4.1 4.9 4.8 4.6	 NA	 5.3	 5.3
900	 12.0	 11.2	 11.0	 11.5 11.6 12.0 11.3 11.0 12.0 11.3	 NA	 12.5	 12.0
1200	 22.8	 23.0	 23.0	 22.6 21.2 21.6 22.8 21.8 21.6 23.0	 NA	 22.8	 23.0
Fusarium	
oxysporum	
300	 3.9	 4.5	 4.4	 4.0	 4.6	 5.4	 4.4	 NA	 4.0	 NA	 4.4	 4.9	 5.4	
600	 8.3	 8.2	 7.6	 8.6	 9.5	 9.7	 7.5	 NA	 6.9	 NA	 7.9	 8.1	 10.8	
900	 15.8	 15.8	 16.8	 17.0	 17.9	 19.4	 13.3	 NA	 14.2	 NA	 15.0	 16.8	 20.0	
1200	 32.0	 29.7	 32.5	 31.8 32.0 33.8 27.8 NA F.4 NA	 30.8	 31.3	 34.3
Drechslera	
halodes	
300	 3.5	 NA	 3.5	 3.5	 3.0	 3.0	 3.9	 3.4	 2.5	 3.6	 3.4	 3.4	 3.5	
600	 6.1	 NA	 7.0	 7.1 7.5 6.1 6.2 6.0 5.1 7.0	 7.0	 6.7	 7.5
900	 14.2	 NA	 14.0	 14.6 14.2 13.6 12.3 13.5 12.6 14.0	 13.7	 12.5	 14.7
1200	 26.4	 NA	 26.7	 26.2 21.5 26.2 25.9 21.3 23.2 21.2	 21.1	 21.2	 27.3
Colletotrichum	
falcatum	
300	 4.4	 3.6	 2.4	 NA 4.2 3.8 3.9 4.3 4.3 5.0	 4.1	 3.0	 4.4
600	 9.2	 9.3	 4.9	 NA 7.5 7.1 8.2 7.9 8.7 9.3	 7.3	 6.1	 9.3
900	 17.8	 18.2	 12.0	 NA	 13.5	 15.1	 15.3	 17.0	 17.4	 17.0	 15.7	 12.7	 18.2	
1200	 23.7	 23.5	 19.8	 NA	 27.9	 21.4	 19.3	 23.5	 22.9	 23.5	 23.2	 25.4	 33.7	
*	NA:	Not	applicable.	
	
3.7.	Antifungal	activity	
	
All	 the	 prepared	 complexes	 showed	 good	 to	 moderate	
activity	 in	 which	 Rh‐HNAMQ	 and	 Ru‐HBAMQ	 showed	 better	
activity	against	maximum	strains	(Table	4).	Due	to	their	polar	
nature	 and	 heterocyclic	 ring	 system	 these	 compounds	 exert	
good	activity	against	certain	species	of	fungi.	
	
4.	Conclusions		
	
In	 conclusion,	we	have	synthesized	mercapto	quinazoline	
compounds	 as	 ligands	 and	 their	 Rh(III),	 Ru(III),	 Ag(I)	 metal	
complexes,	 characterized	 them,	 and	 investigated	 their	
antimicrobial	 activity	 against	 different	 species	 of	
microorganisms.	The	 results	 indicate	 that	 the	majority	of	 the	
compounds	 found	 to	 possess	 interesting	 antibacterial	
activities	 against	 tested	 bacterial	 strains	 when	 compared	 to	
standard	 drug	 streptomycin.	 Certain	 of	 the	 synthesized	
compounds	 found	 to	 possess	 moderate	 to	 good	 antifungal	
activity	when	compared	to	standard	drug	itrazole.		
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